ACADIA Pharmaceuticals

Pharmaceuticals & Biotech

ACADIA Pharmaceuticals Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinsons disease psychosis. It is also developing AGN XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma, both in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development for schizophrenia in collaboration with Meiji Seika Kaisha. The product candidates in the company'?s pipeline emanate from discoveries made using its proprietary drug discovery platform. Acadia Pharmaceuticals extended its drug discovery and development research agreement with Allergan to March 2012.[citation needed] The agreement stipulates both parties will work together for the discovery of new therapeutics for glaucoma and ophthalmic conditions.

Highest paying job titles at ACADIA Pharmaceuticals include Psychiatrist, Chief Financial Officer, and Medical Director


Market Cap$7.8 billion
Revenue$232 million
5 Year Trend+279.7%
Net Income-$262.3 million
Annual Report
Total value of jobs:
Total Jobs:
Average Pay:
Total Experts:
% Masters:

Top Experts at ACADIA Pharmaceuticals

ACADIA Pharmaceuticals Salaries




Average Salary:$90,000

Chief Financial Officer



Average Salary:$175,000

Medical Director



Average Salary:$114,444

Clinical Director



Average Salary:$110,000

View All Salaries